BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Faust N, Yamada A, Haider H, Komaki Y, Komaki F, Micic D, Sakuraba A. Systemic review and network meta-analysis: Prophylactic antibiotic therapy for spontaneous bacterial peritonitis. World J Hepatol 2020; 12(5): 239-252 [PMID: 32547691 DOI: 10.4254/wjh.v12.i5.239]
URL: https://www.wjgnet.com/1948-5182/full/v12/i5/239.htm
Number Citing Articles
1
Tahir Zaman, Muhammad Bilal Ahmed Attari, Adeel Ahmad, Muhammad Ahsan Butt, Khurram Fayyaz, Syeda Aeman Zubair. Comparison of Rifaximin Alone and With Quinolones in the Primary Prevention of Spontaneous Bacterial Peritonitis in Patients With Decompensated Chronic Liver DiseaseCureus 2024;  doi: 10.7759/cureus.55251
2
S. S. Kuzminykh, O. V. Makarenko . Pharmacoeconomic Analysis of N-Chlorotaurine Infusion Therapy in the Treatment of Patients with PeritonitisUkraïnsʹkij žurnal medicini, bìologìï ta sportu 2022; 7(5): 114 doi: 10.26693/jmbs07.05.114
3
Petros Ioannou, Stamatis Karakonstantis, Jeroen Schouten, Tomislav Kostyanev, Esmita Charani, Vera Vlahovic-Palcevski, Diamantis P. Kofteridis. Indications for medical antibiotic prophylaxis and potential targets for antimicrobial stewardship intervention: a narrative reviewClinical Microbiology and Infection 2022; 28(3): 362 doi: 10.1016/j.cmi.2021.10.001
4
Roman Maslennikov, Aliya Alieva, Elena Poluektova, Yury Zharikov, Andrey Suslov, Yana Letyagina, Ekaterina Vasileva, Anna Levshina, Evgenii Kozlov, Vladimir Ivashkin. Sarcopenia in cirrhosis: Prospects for therapy targeted to gut microbiotaWorld Journal of Gastroenterology 2023; 29(27): 4236-4251 doi: 10.3748/wjg.v29.i27.4236
5
Bálint Baráth, Dávid K. Jász, Tamara Horváth, Bence Baráth, Gergely Maróti, Gerda Strifler, Gabriella Varga, Lilla Sándor, Domonkos Perényi, Szabolcs Tallósy, Tibor Donka, Péter Jávor, Mihály Boros, Petra Hartmann. Mitochondrial Side Effects of Surgical Prophylactic Antibiotics Ceftriaxone and Rifaximin Lead to Bowel Mucosal DamageInternational Journal of Molecular Sciences 2022; 23(9): 5064 doi: 10.3390/ijms23095064
6
Daniel Pörner, Sibylle Von Vietinghoff, Jacob Nattermann, Christian P Strassburg, Philipp Lutz. Advances in the pharmacological management of bacterial peritonitisExpert Opinion on Pharmacotherapy 2021; 22(12): 1567 doi: 10.1080/14656566.2021.1915288
7
José M. Porcel. Expert Review on Contemporary Management of Common Benign Pleural EffusionsSeminars in Respiratory and Critical Care Medicine 2023; 44(04): 477 doi: 10.1055/s-0043-1769096
8
Mykola Tutchenko, Diana Rudyk, Mykola Besedinskyi, Sergey Chub. SPONTANEOUS BACTERIAL PERITONITISEastern Ukrainian Medical Journal 2024; 12(2): 221 doi: 10.21272/eumj.2024;12(2):221-228
9
Federica Di Vincenzo, Alberto Nicoletti, Marcantonio Negri, Federica Vitale, Lorenzo Zileri Dal Verme, Antonio Gasbarrini, Francesca Romana Ponziani, Lucia Cerrito. Gut Microbiota and Antibiotic Treatments for the Main Non-Oncologic Hepato-Biliary-Pancreatic DisordersAntibiotics 2023; 12(6): 1068 doi: 10.3390/antibiotics12061068
10
Harry D Zacharias, Fady Kamel, Jaclyn Tan, Nina Kimer, Lise Lotte Gluud, Marsha Y Morgan. Rifaximin for prevention and treatment of hepatic encephalopathy in people with cirrhosisCochrane Database of Systematic Reviews 2023; 2023(7) doi: 10.1002/14651858.CD011585.pub2
11
Aldo Torre, Jacqueline Córdova-Gallardo, Alberto C Frati Munari. Rifaximin Alfa and Liver Diseases: More Than a Treatment for Encephalopathy, a Disease ModifierTherapeutics and Clinical Risk Management 2023; : 839 doi: 10.2147/TCRM.S425292